Evidence map›Paper›PMID 20687085›Full record

SynthesisThe Cochrane database of systematic reviews2010

Cervical preparation for second trimester dilation and evacuation.

Sara J Newmann, Andrea Dalve-Endres, Justin T Diedrich, Jody E Steinauer, Karen Meckstroth, Eleanor A Drey

2 registry-linked trialsAbstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01818414 naterminatednot on this mapstarted 2013, after this paper: background citation

Dilapan-S With Adjunctive Misoprostol for Same-day Second Trimester Dilation and Evacuation: A Randomized Trial

TypeinterventionalSponsorUniversity of PittsburghRan2013 to 2014Enrolled29ConditionsTherapeutic AbortionArmsMisoprostol, Folic Acid
NCT05579288 early_phase1unknown statusnot on this mapstarted 2022, after this paper: background citation

Use of Nitrous Oxide for Pain Alleviation in Women Undergoing Osmotic Dilator Insertion for Second Trimester Dilatation and Evacuation

TypeinterventionalSponsorSheba Medical CenterRan2022 to 2024Enrolled60ConditionsPain Alleviation, Dilatation and Evacuation, Laminaria Placement, Nitrous OxideArmsNitrous oxide (N2O/O2), Oxygen (O2)
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sara J NewmannObstetrics and Gynecology and Reproductive Sciences, University of California, San Francisco General Hospital, 1001 Potrero Avenue Ward 6D, San Francisco, California, USA, CA 94110.
Andrea Dalve-Endres
Justin T Diedrich
Jody E Steinauer
Karen Meckstroth
Eleanor A Drey
University of California, San Francisco · USSan Francisco General Hospital · USUniversity of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAbortion during the second trimester of pregnancy accounts for 10-15% of abortions performed worldwide. Dilation and evacuation (D&E) is the preferred method of second-trimester abortion in most parts of the developed world. Cervical preparation is recommended for dilation and curettage (D&C) after 12 weeks gestation and is standard practice for D&E beyond 14 weeks gestation. Prostaglandins, osmotic dilators, and Foley balloon catheters have been used and studied as cervical preparation prior to second-trimester D&E. However, no consensus exists as to which cervical preparation method is superior with regards to safety, procedure time, need for additional dilation, ability to perform the procedure, or patient and provider acceptability. Despite the fact that the advent of osmotic dilation has improved the safety of the D&E procedure during the second trimester, it is unclear whether a certain type of osmotic dilator is superior to another or whether osmotic dilation with adjuvant prostaglandin is superior to osmotic dilation alone or to prostaglandins alone.

objectivesThis review evaluates cervical preparation methods for second-trimester surgical abortion with respect to differences in procedure time, dilation achieved, need for additional dilation, complications, ability to complete the procedure, patient pain scores, and patient and provider acceptability and satisfaction. SEARCH STRATEGY: We searched for trials of cervical preparation prior to second-trimester D&E. SELECTION CRITERIA: We included all randomized controlled trials that compared osmotic, mechanical, antiprogesterone, prostaglandin, or other medical agents of cervical preparation for second-trimester surgical abortion from 14-24 weeks of gestation. DATA COLLECTION AND ANALYSIS: Data were abstracted by two authors and data entry was verified by a third author. Mean difference and Peto Odds Ratio were calculated. MAIN

resultsOsmotic dilators were found to be superior to prostaglandins with respect to cervical dilation throughout the second trimester and with respect to procedure time within the early second trimester. Addition of prostaglandins to osmotic dilators was not found to increase cervical dilation, except after 19 weeks gestation, however, no impact was seen on procedure time. Addition of Mifepristone to misoprostol was found to improve cervical dilation, yet increase procedure time and frequency of pre-procedural expulsions. Two-day cervical preparation was found to produce greater cervical preparation than one-day, but had no impact on procedure time. Serious complication rates or ability to complete the procedure did not differ significantly between any of the preparation methods reviewed. AUTHORS'

conclusionsCervical preparation with osmotic dilators and/or misoprostol before second-trimester D&E is safe and effective. Osmotic dilators appear to provide superior cervical dilation when compared to prostaglandins alone or when combined with prostaglandins, however this difference in cervical dilation does not appear to result in differences in procedure time or complication rates. There does not appear to be clear clinical benefit from two days of cervical preparation compared to one-day prior to second-trimester D&E below 19 weeks gestational duration. Mifepristone plus misoprostol was associated with high rates of pre-procedural expulsions and does not appear to be a useful method of cervical preparation before second-trimester dilation and evacuation. Same-day procedures appear to be a safe and reasonable option in the early second trimester, however, more research is needed to assess the effectiveness and safety of same-day procedures in the later second trimester.

Indexed as

Abortifacient AgentsProstaglandinsAbortion, InducedCervix UteriExtraction, ObstetricalFemaleHumansLabor Stage, FirstLaminariaMifepristoneMisoprostolOsmosisPolymersPregnancyPregnancy Trimester, SecondPreoperative CareAbortifacient AgentsdilapanMifepristoneMisoprostolPolymersProstaglandins

Identifiers

PMID20687085
OpenAlexW1717070957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.